Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia

Prajwal Boddu; Hagop Kantarjian; Farhad Ravandi; Guillermo Garcia-Manero; Gautam Borthakur; Michael Andreeff; Elias J. Jabbour; Christopher B. Benton; Courtney D. DiNardo; Marina Konopleva; Naval Daver; Keyur Patel; Koichi Takahashi; Rashmi Kanagal-Shamanna; Jorge Cortes; Tapan Kadia

doi:10.1080/10428194.2017.1422864

Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia

Prajwal Boddu, Hagop Kantarjian, Farhad Ravandi, Guillermo Garcia-Manero, Gautam Borthakur, Michael Andreeff, Elias J. Jabbour, Christopher B. Benton, Courtney D. DiNardo, Marina Konopleva, Naval Daver, Keyur Patel, Koichi Takahashi, Rashmi Kanagal-Shamanna, Jorge Cortes, Tapan Kadia

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	2238-2241
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	59
Issue number	9
DOIs	https://doi.org/10.1080/10428194.2017.1422864
State	Published - Sep 2 2018
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2017.1422864

Cite this

Boddu, P., Kantarjian, H., Ravandi, F., Garcia-Manero, G., Borthakur, G., Andreeff, M., Jabbour, E. J., Benton, C. B., DiNardo, C. D., Konopleva, M., Daver, N., Patel, K., Takahashi, K., Kanagal-Shamanna, R., Cortes, J., & Kadia, T. (2018). Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia. Leukemia and Lymphoma, 59(9), 2238-2241. https://doi.org/10.1080/10428194.2017.1422864

Boddu, P, Kantarjian, H, Ravandi, F, Garcia-Manero, G, Borthakur, G, Andreeff, M, Jabbour, EJ, Benton, CB, DiNardo, CD, Konopleva, M, Daver, N, Patel, K, Takahashi, K, Kanagal-Shamanna, R, Cortes, J & Kadia, T 2018, 'Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia', Leukemia and Lymphoma, vol. 59, no. 9, pp. 2238-2241. https://doi.org/10.1080/10428194.2017.1422864

@article{0b031a938b2047bfaa65759da20f84f1,

title = "Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia",

author = "Prajwal Boddu and Hagop Kantarjian and Farhad Ravandi and Guillermo Garcia-Manero and Gautam Borthakur and Michael Andreeff and Jabbour, {Elias J.} and Benton, {Christopher B.} and DiNardo, {Courtney D.} and Marina Konopleva and Naval Daver and Keyur Patel and Koichi Takahashi and Rashmi Kanagal-Shamanna and Jorge Cortes and Tapan Kadia",

note = "Funding Information: This study was supported in part by the MD Anderson Cancer Center Support Grant P30 CA016672 and Award Number P01 CA049639.",

year = "2018",

month = sep,

day = "2",

doi = "10.1080/10428194.2017.1422864",

language = "English (US)",

volume = "59",

pages = "2238--2241",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "9",

}

TY - JOUR

T1 - Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia

AU - Boddu, Prajwal

AU - Kantarjian, Hagop

AU - Ravandi, Farhad

AU - Garcia-Manero, Guillermo

AU - Borthakur, Gautam

AU - Andreeff, Michael

AU - Jabbour, Elias J.

AU - Benton, Christopher B.

AU - DiNardo, Courtney D.

AU - Konopleva, Marina

AU - Daver, Naval

AU - Patel, Keyur

AU - Takahashi, Koichi

AU - Kanagal-Shamanna, Rashmi

AU - Cortes, Jorge

AU - Kadia, Tapan

N1 - Funding Information: This study was supported in part by the MD Anderson Cancer Center Support Grant P30 CA016672 and Award Number P01 CA049639.

PY - 2018/9/2

Y1 - 2018/9/2

UR - http://www.scopus.com/inward/record.url?scp=85040989044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040989044&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1422864

DO - 10.1080/10428194.2017.1422864

M3 - Letter

C2 - 29338567

AN - SCOPUS:85040989044

SN - 1042-8194

VL - 59

SP - 2238

EP - 2241

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 9

ER -

Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this